Page last updated: 2024-09-03

reboxetine and apomorphine

reboxetine has been researched along with apomorphine in 1 studies

Compound Research Comparison

Studies
(reboxetine)
Trials
(reboxetine)
Recent Studies (post-2010)
(reboxetine)
Studies
(apomorphine)
Trials
(apomorphine)
Recent Studies (post-2010) (apomorphine)
6261931849,205287780

Protein Interaction Comparison

ProteinTaxonomyreboxetine (IC50)apomorphine (IC50)
Tryptophan 5-hydroxylase 1Rattus norvegicus (Norway rat)0.22
D(2) dopamine receptorHomo sapiens (human)0.0146
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)7.75
DRattus norvegicus (Norway rat)0.4744
D(3) dopamine receptorRattus norvegicus (Norway rat)0.1432
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.063
D(2) dopamine receptorBos taurus (cattle)0.3385
D(1A) dopamine receptorHomo sapiens (human)0.025
D(4) dopamine receptorHomo sapiens (human)0.025
D(1B) dopamine receptorHomo sapiens (human)0.025
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.063
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.063
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)7.75
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.1432
D(4) dopamine receptorRattus norvegicus (Norway rat)0.1432
D(3) dopamine receptorHomo sapiens (human)0.025
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)7.75
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0813
E3 ubiquitin-protein ligase Mdm2Homo sapiens (human)0.205
5-hydroxytryptamine receptor 4 Rattus norvegicus (Norway rat)1.35
DBos taurus (cattle)0.3385

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, MJ; Cheng, FH; Daiss, JO; Mills, JS; Montana, JG; Naylor, RJ; Ngan, MP; Rudd, JA; Tacke, R; Wai, MK; Warneck, JB1

Other Studies

1 other study(ies) available for reboxetine and apomorphine

ArticleYear
Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
    Toxicology and applied pharmacology, 2008, Nov-01, Volume: 232, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Animals; Antiemetics; Antineoplastic Agents; Apomorphine; Cisplatin; Cyclohexanols; Ferrets; Male; Morpholines; Reboxetine; Serotonin Antagonists; Venlafaxine Hydrochloride; Vomiting

2008